Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 3/20 | 0.64 |
| ▸ | CTSS | P25774 | 3/20 | 0.64 |
| ▸ | CTSK | P43235 | 3/20 | 0.64 |
| ▸ | CTSH | P09668 | 1/20 | 0.64 |
| ▸ | C5AR1 | P21730 | 2/20 | 0.62 |
| ▸ | APLNR | P35414 | 2/20 | 0.61 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.60 |
| ▸ | GLP1R | P43220 | 9/20 | 0.58 |
| ▸ | GCGR | P47871 | 8/20 | 0.58 |
| ▸ | GIPR | P48546 | 5/20 | 0.57 |
| ▸ | NPY1R | P25929 | 1/20 | 0.56 |
| ▸ | NPY2R | P49146 | 1/20 | 0.56 |
| ▸ | NPY4R | P50391 | 1/20 | 0.56 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30894433 | 0.93 | APLNR (0.60) | CTSLCTSSCTSKCTSHC5AR1 | |
| SCHEMBL30717268 | 0.92 | C5AR1 (0.65) | C5AR1APLNRKEAP1GLP1RGCGR | |
| SCHEMBL31182480 | 0.91 | C5AR1 (0.64) | CTSLCTSSCTSKCTSHC5AR1 | |
| SCHEMBL30631666 | 0.91 | CTSL (0.62) | CTSLCTSSCTSKCTSHC5AR1 | |
| SCHEMBL30432727 | 0.90 | APLNR (0.63) | CTSLCTSSCTSKCTSHC5AR1 | |
| SCHEMBL31544061 | 0.90 | C5AR1 (0.73) | CTSLCTSSCTSKCTSHC5AR1 | |
| SCHEMBL31182802 | 0.89 | KEAP1 (0.66) | CTSLCTSSCTSKCTSHC5AR1 | |
| SCHEMBL30436302 | 0.88 | GLP1R (0.67) | C5AR1KEAP1GLP1RGCGRNPY1R | |
| SCHEMBL30487564 | 0.88 | C5AR1 (0.71) | CTSLCTSSCTSKCTSHC5AR1 | |
| SCHEMBL29737187 | 0.87 | C5AR1 (0.75) | C5AR1KEAP1GLP1RGCGRNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230040544-A1 | COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) | SAREPTA THERAPEUTICS, INC. | 2023-02-09 | — | — | US | disclosed |